Naltrexone renders one-session exposure therapy less effective: A controlled pilot study

Journal of Anxiety Disorders

Volumn 21, Issue 1, 2007, Pages 142-152

  Kozak, Andrea T ^a   Spates, C Richard ^a   McChargue, Dennis E ^b,c   Bailey, Katherine C ^b   Schneider, Kristin L ^b   Liepman, Michael R ^a,d  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Behavioral assessment; Endogenous opiates; Naltrexone; Phobias

Indexed keywords

NALTREXONE; OPIATE RECEPTOR; PLACEBO;

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CONTROLLED STUDY; DIZZINESS; DRUG EXPOSURE; DRUG TOLERABILITY; FEAR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHOBIA; PILOT STUDY; RATING SCALE; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESCAPE REACTION; FEAR; FEMALE; HUMANS; INTERVIEWS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PHOBIC DISORDERS; PILOT PROJECTS; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX;

EID: 33846187665     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2006.03.011     Document Type: Article

References (26)

1. Amanzio M., and Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. The Journal of Neuroscience 19 1 (1999) 484-494
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: Author.
3. Arntz A., Merckelbach H., and de Jong P. Opioid antagonist affects behavioral effects of exposure in vivo. Journal of Consulting and Clinical Psychology 61 5 (1993) 865-870
4. Barlow D.H. Anxiety and its disorders: the nature and treatment of anxiety and panic (1988), The Guilford Press, New York
5. Besson A., Privat A.M., Eschalier A., and Fialip J. Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats. Psychopharmacology (Berl) 123 (1996) 71-78
6. Booth R., and Rachman S. The reduction of claustrophobia-I. Behaviour Research and Therapy 30 3 (1992) 207-221
7. Carr J.E. Neuroendocrine and behavioral interaction in exposure treatment of phobic avoidance. Clinical Psychology Review 16 1 (1996) 1-15
8. Diggle P.J., Liang K.Y., and Zeger S.L. Analysis of longitudinal data (1994), Clarendon Press, Oxford, England
9. Egan K.J., Carr J.E., Hunt D.D., and Adamson R. Endogenous opiate system and systematic desensitization. Journal of Consulting and Clinical Psychology 56 2 (1988) 287-291
10. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV Axis I Disorders-Non-Patient edition (1996), Biometrics Research Department, New York
11. Haour F. Mechanisms of the placebo effect and conditioning. Neuroimmunomodulation 12 (2005) 195-200
12. Hunziker M.H.L. Opioid nature of learned helplessness and stress-induced analgesia observed without re-exposure. Behavioural Pharmacology 3 (1992) 117-121
13. Hyson R.L., Ashcraft L.J., Drugan R.C., Grau J.W., and Maier S.F. Extent and control of shock affects naltrexone sensitivity of stress-induced analgesia and reactivity to morphine. Pharmacology, Biochemistry and Behavior 17 (1982) 1019-1025
14. Koch E.I., Spates C.R., and Himle J.A. Comparison of behavioral and cognitive-behavioral one-session exposure treatments for small animal phobias. Behaviour Research and Therapy 42 (2004) 1483-1504
15. Kranzler H.R., Kadden R.M., Babor T.F., Tennen H., and Rounsaville B.J. Validity of the SCID in substance abuse patients. Addiction 91 6 (1996) 859-868
16. Maier S.F., Sherman J.E., Lewis J.W., Terman G.W., and Liebeskind J.C. The opioid/nonopioid nature of stress-induced analgesia and learned helplessness. Journal of Experimental Psychology: Animal Behavior Processes 9 1 (1983) 80-90
17. Marks I.M. Fears, phobias, and rituals: panic, anxiety, and their disorders (1987), Oxford University Press, New York
18. Menzies R.G., and Clarke J.C. A comparison of in vivo and vicarious exposure in the treatment of childhood water phobia. Behaviour Research and Therapy 31 1 (1993) 9-15
19. Merluzzi T.V., Taylor C.B., Boltwood M., and Gotestam K.G. Opioid antagonist impedes exposure. Journal of Consulting and Clinical Psychology 59 3 (1991) 425-430
20. Ost L.-G., Johansson J., and Jerremalm A. Individual response patterns and the effects of different behavioral methods in the treatment of claustrophobia. Behaviour Research and Therapy 20 (1982) 445-460
21. Rang H.P., and Dale M.M. Pharmacology (1991), Churchill Livingstone Inc, New York
22. Riskind J.H., Beck A.T., Berchick R.J., Brown G., and Steer R.A. Reliability of DSM-III diagnoses for major depression and generalized anxiety disorder using the structured clinical interview for DSM-III. Archives of General Psychiatry 44 (1987) 817-820
23. Thyer B.A., and Matthews J. The effect of phobic anxiety on plasma β-endorphin: a single-subject experiment. Behaviour Research and Therapy 24 2 (1986) 237-241
24. In: Venes D., Thomas C.L., Egan E.J., Morelli N.A., Nell A.D., and Houska A. (Eds). Taber's cyclopedic medical dictionary. 19th ed. (2001), F.A. Davis Company, Philadelphia, PA
25. Verbeke G., and Molenberghs G. Linear mixed models for longitudinal data (2000), Springer, New York
26. Wolpe J. The practice of behavior therapy (1969), Pergamon Press, New York